Innovative Product Pipeline All G is developing a portfolio of high-value milk proteins through precision fermentation, starting with bovine lactoferrin and rapidly expanding into human milk proteins. This presents opportunities to collaborate with companies in infant nutrition, functional foods, and specialized dietary supplements seeking advanced protein ingredients.

Strategic Market Entry With the upcoming launch of recombinant bovine lactoferrin in early 2026, All G offers a cutting-edge ingredient that can meet the demands of premium infant formula and dairy innovation markets, making it a strong partner for nutraceutical and formula manufacturers aiming to differentiate their products.

Diversified Applications Beyond nutrition, All G is exploring the use of human and bovine milk proteins for skin care formulations, opening avenues for partnerships with cosmetic and personal care brands interested in bioactive ingredients derived from sustainable biotech processes.

Growing Financial Backing With a recent funding round of $6.6 million and total funding reaching $24 million, All G is well-positioned to scale production and develop partner collaborations, making it attractive for investors and collaborators seeking innovative biotech solutions.

Sustainability and Innovation Focus All G’s emphasis on precision fermentation to produce high-value milk proteins aligns with industry trends toward sustainable, animal-free ingredient sourcing, appealing to companies and markets prioritizing eco-friendly and ethical product development.